Ernexa Therapeutics Inc. (Nasdaq: ERNA) ("Ernexa" or the "Company"), an industry innovator developing novel cell therapies for the treatment of advanced ...

FOR IMMEDIATE RELEASE REFRESCO TO ACQUIRE SUNOPTA FOR $6.50 PER SHARE IN CASH Strategic combination expands Refresco's North American capabilities SunOpta common ...